1. Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer;Leitzel;J. Clin. Oncol.,1995
2. Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer;Houston;Br. J. Cancer,1999
3. HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer;Elledge;Clin. Cancer Res.,1998
4. Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy;Archer;Br. J. Cancer,1995
5. Blanco AR, De Laurentils M, Carlomagno C, et al. 20 year update of the Naples gun trial of adjuvant breast cancer therapy: evidence of interaction between c-erbB2 expression and Tamoxifen efficacy. Proc Am Soc Clin Oncol 1998, 17, (abstract 373), 97a.